← brief for 2026-10-11 · Slowing decline

GLP-1-based therapies in lung diseases.

Paper No results yet Peer reviewed

Key takeaways

This review discusses how diabetes drugs might help with lung diseases. It notes these drugs have benefits for the heart and kidneys. It is a review of existing ideas, not a new trial with results. There are no new results from this specific paper.

Who did this work

O'Callaghan M · Boon MR · Braunstahl GJ · Koudstaal T · van Rossum EFC · Moor K · Wijsenbeek M

Source

Paper · PubMed, the drug frontier · 2026 Oct 11
https://pubmed.ncbi.nlm.nih.gov/42860278/